Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allozyne Inc.

www.allozyne.com

Latest From Almirall SA

Almirall's "Perfect Storm": How Will It Recover?

Changes in business processes in the US, and the launch of new products including a competitively priced Skilarence in the EU, are expected to help Almirall recover from setbacks over the coming months.

Business Strategies Sales & Earnings

Spanish Biotech Star Oryzon Slumps After Roche Rejection

Barcelona-based Oryzon Genomics remains upbeat about the prospects for 'a first-in-class, best-in-class LSD1 inhibitor' for cancer even though Roche has walked away from what was a potentially lucrative partnership.

Deals Companies

Almirall Knocked Back By US Woes, Could Affect Other Companies Too

Spain’s Almirall has suffered business setbacks in the US - including in its patient assistance program - that have forced the mid-sized drug maker to issue a profit warning, triggering of a sharp slide in its share price.

Sales & Earnings Reimbursement

Pipeline Watch: Phase III Progress With Anacetrapib, ALKS 3831 And LentiGlobin

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allozyne Inc.
  • Senior Management
  • Meenu Chhabra, Pres. & CEO
    Kenneth Grabstein, PhD, CSO
  • Contact Info
  • Allozyne Inc.
    Phone: (206) 518-5700
    1600 Fairview Ave. E
    Ste. 300
    Seattle, WA 98102
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register